Exoskeleton Market Boosting Due To Growing Technological Advancements Till 2025: Grand View Research, Inc.

The global exoskeleton market is expected to reach USD 3.3 billion by 2025, according to a new report published by Grand View Research. Key factors driving the market expansion include the increasing number of U.S. FDA products, growing demand for exoskeletons in rehabilitation, assisted walking, military applications, and industrial applications. 

The market is evolving rapidly due to the increasing adoption of exoskeleton technology in the developed regions. The growing geriatric population coupled with increasing number of people suffering with paraplegia, tetraplegia, and other spinal cord injuries are major factors boosting the usage rates of exoskeletons. 

The exoskeleton market has gained high momentum after the launch of products such as ReWalk bionic suit, Ekso GT exoskeleton. Moreover, with the U.S. FDA approving the Parker Indego, commercialization of exoskeleton devices is expected to increase significantly over the next few years. 



In the U.S., the Defense Advanced Research Projects Agency (DARPA), National Aeronautics and Space Administration (NASA), and National Institute of Health (NIH) have significantly contributed toward technology development, research funding, and commercialization of these devices.

  • For instance, in 2014, Ekso Bionics received a P20 Exploratory Grant from the NIH to continue the development of an exoskeleton prototype for children.
  • In October, 2015, Parker Hannifin Corporation announced that it had agreed to supply Indego exoskeleton for a 4-year multicenter study for the Department of Defense, which was funded by the U.S. Department of Defense and the Congressionally Directed Medical Research Programs. 

In the EU, the Robo-Mate project, which comprises of 12 partners from 7 European nations, has received a total funding of Euro 4.5 million by the 7th Framework Program for Research and Technological Development of the European Union. Furthermore, classification of Cyberdyne HAL exoskeleton as medical device in the EU and Japan has reinforced the growth prospects and improved the reimbursement scenario. 

Browse full research report on Exoskeleton Market: www.grandviewresearch.com/industry-analysis/exoskeleton-market 

                                                                                             
Further key findings from the report suggest:

  • The data published by the International Federation of Robotics suggests that in 2014, nearly 272 exoskeletons were sold commercially, and this number is anticipated to grow rapidly over the next few years.
  • In 2015, the healthcare segment accounted for the maximum revenue share of 54.1%. The use of exoskeletons for rehabilitation and assisted living services is a key factor driving the segments growth. However, the industrial segment is expected to emerge as the fastest growing with a high CAGR of 58.8%. Increasing age of workforce coupled with growing healthcare disorders are expected to boost the use of automation and drive the sales of exoskeletons over the forecast period.
  • In 2015, North America was a clear leader with a revenue share of 49.8%. The research on exoskeletons was primarily initiated with the USD 50 million funding received from DARPA, and subsequent grants from NIH and NASA have contributed to the development of a strong ecosystem for the proliferation of exoskeleton technology. Moreover, the U.S. Department of Veteran Affairs had issued a national coverage policy for ReWalk robotic exoskeleton systems for eligible veterans with spinal cord injury. This policy is expected to significantly benefit the veterans and propel the usage rates over the forecast period
  • Asia Pacific is expected to emerge as the fastest growing region with a CAGR of 57.4% during the forecast period. The growing geriatric population in Japan and China, increase in the spinal cord injuries, and growing industrialization in this region are expected promote the utilization of exoskeletons for healthcare and industrial applications.
  • The exoskeleton market is presently dominated by few key participants such as ReWalk, Ekso Bionics, Cyberdyne, and Lockheed Martin. Some of the new players include Rex Bionics, Hocoma, Panasonic- ActiveLink and Parker Hannifin Corporation. Introduction of low cost exoskeletons is expected to increase the competition and is also expected to benefit several patients over the forecast period

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                                                                                           

Grand View Research has segmented the exoskeleton market by type, technology, end use, and region:

Exoskeleton Market Technology (Type) Outlook (Market revenue in USD Million, 2013 - 2025)
  • Mobile Exoskeleton
  • Stationary Exoskeleton
Exoskeleton Mobile Technology Market Outlook (Market Revenue in USD Million, 2013 - 2025)
  • Active
  • Passive
Exoskeleton Stationary Technology Outlook (Market Revenue in USD Million, 2013 - 2025)
  • Active
  • Passive
Exoskeleton Market Technology (Drive System) Outlook (Market Revenue in USD Million, 2013 - 2025)
  • Pneumatic Actuator
  • Hydraulic
  • Electric Servo
  • Electric Actuator
  • Fully Mechanical
  • Shape Memory Alloy Actuator
Exoskeleton Market End-User Outlook (Market Revenue in USD Million, 2013 - 2025)
  • Healthcare
  • Military
  • Industrial
Exoskeleton Market Regional Outlook (Market Revenue in USD Million, 2013 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-exoskeleton-market         
                                            
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: www.grandviewresearch.com

Comments

Popular posts from this blog

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Rising Adoption Of Medical Animation As A Tool For Marketing & Education to Drive Medical Animation Market Till 2025: Grand View Research, Inc.